ADELE CLAY: Open Payments
NPI 1881670933 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 28 payments from 13 companies in 2025. Trend: 2023 $945 · 2024 $806 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 6 | $119 |
| Exeltis, USA Inc. | 5 | $107 |
| Sage Therapeutics, LLC | 3 | $75 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $40 |
| CooperSurgical, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $26 |
Products named: SLYND, FEMLYV, ZURZUVAE, INJECTAFER, MYFEMBREE, Cologuard Collection Kit, Paragard T 380A, Veozah.
Industry payments across CT — which companies pay providers there.
